Key issues in the persistence of poliomyelitis in Nigeria: A case-control study

The Lancet Global Health

Volumn 2, Issue 2, 2014, Pages

  Mangal, Tara D ^a   Aylward, R Bruce ^b   Mwanza, Michael ^c   Gasasira, Alex ^d   Abanida, Emmanuel ^e   Pate, Muhammed A ^f   Grassly, Nicholas C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c WHO Nigeria   (Nigeria)

^d Federal Ministry of Health ^*  (Congo)

^e NATIONAL PRIMARY HEALTH CARE DEVELOPMENT AGENCY   (Nigeria)

^f Federal Ministry of Health   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ATTITUDE TO HEALTH; CASE CONTROL STUDY; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INCIDENCE; NIGERIA; POLIOMYELITIS; POLIOMYELITIS VIRUS; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; TRANSMISSION; TREATMENT OUTCOME;

ATTITUDE TO HEALTH; CASE-CONTROL STUDIES; HUMANS; INCIDENCE; NIGERIA; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84892989274     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(13)70168-2     Document Type: Article

References (27)

1. Resolution WHA65.5, Poliomyelitis: intensification of the global eradication initiative. May 26, 2012 Agenda item 13.10 2012, World Health Assembly, World Health Organization, Geneva.
2. Tracking progress towards global polio eradication, 2011-2012. Wkly Epidemiol Rec 2013, 88:153-160. WHO.
3. Progress towards global interruption of wild poliovirus transmission, January 2012-March 2013. Wkly Epidemiol Rec 2013, 88:181-187. WHO.
4. Progress towards interrupting wild poliovirus transmission worldwide: January 2010-March 2011. Wkly Epidemiol Rec 2011, 86:199-204. WHO.
5. Emergency Action Plan, May-December 2011 2011, National Primary Health Care Development Agency, National Primary Health Care Development Agency, Abuja.
6. 2012 Nigeria Polio Eradication Emergency Plan 2012, National Primary Health Care Development Agency, Nigeria Federal Ministry of Health, Abuja.
7. Advisory committee on poliomyelitis eradication: recommendations on the use of bivalent oral poliovirus vaccine types 1 and 3. Wkly Epidemiol Rec 2009, 84:289-290. WHO.
8. Polio eradication and endgame strategic plan Global Polio Eradication Initiative, (accessed June 15, 2013). http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/PEESP_EN_US.pdf.
9. Nigeria Demographic and Health Survey 2008 2009, National Population Commission (NPC) [Nigeria], ICF MacroICF Macro, National Population Commission and ICF Macro, Abuja, Nigeria.
10. Jenkins HE, Aylward RB, Gasasira A, et al. Effectiveness of immunization against paralytic poliomyelitis in Nigeria. N Engl J Med 2008, 359:1666-1674.
11. Sutter RW, John TJ, Jain H, et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet 2010, 376:1682-1688.
12. O'Reilly KM, Durry E,Islam O, et al. The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis. Lancet 2012, 380:491-498.
13. Poliomyelitis vaccination in Ibadan, Nigeria, during 1964 with oral vaccine (Sabin strains). Bull World Health Organ 1966, 34:865-876. Poliomyelitis Commission of the Western Region Ministry of Health.
14. Nigeria Global Communication Indicators PolioInfo, (accessed June 15, 2013). http://polioinfo.org/media_content/nigeria/data_profiles/DI_Profile_nigeria_2012_Q3.pdf.
15. A new strategy for the 'polio endgame' Global Polio Eradication Initiative, (accessed Aug 28, 2012). http://www.polioeradication.org/Portals/0/Document/AboutUs/Governance/IMB/5IMBMeeting/1.2d_5IMB.pdf.
16. Jenkins HE, Aylward RB, Gasasira A, et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 2010, 362:2360-2369.
17. El-Sayed N, El-Gamal Y, Abbassy A-A, et al. Monovalent type 1 oral poliovirus vaccine in newborns. N Engl J Med 2008, 359:1655-1665.
18. Cáceres VM, Sutter RW Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis 2001, 33:531-541.
19. Grassly NC, Wenger J, Durrani S, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet 2007, 369:1356-1362.
20. Posey DL, Linkins RW, Oliveira MJC, Monteiro D, Patriarca PA The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis 1997, 175:S258-S263.
21. Myaux JA, Unicomb L, Besser RE, et al. Effect of diarrhea on the humoral response to oral polio vaccination. Pediatr Infect Dis J 1996, 15:204-209.
22. Polio's last stand? Report of the Independent Monitoring Board of the Global Polio Eradication Initiative Independent Monitoring Board of the Global Polio Eradication Initiative, (accessed June 15, 2013). http://www.polioeradication.org/Portals/0/Document/Aboutus/Governance/IMB/7IMBMeeting/7IMB_Report_EN.pdf.
23. Nigeria Global Communication Indicators PolioInfo, (accessed June 15, 2013). http://polioinfo.org/downloads/di_Profile_nigeria.pdf.
24. Annual Report 2012 Global Polio Eradication Initiative, (accessed Oct 1, 2013). http://www.polioeradication.org/Portals/0/Document/AnnualReport/AR2012/GPEI_AR2012_A4_EN.pdf.
25. Ten months and counting Independent Monitoring Board of the Global Polio Eradication Initiative, (accessed March 28, 2012). http://www.polioeradication.org/portals/0/document/aboutus/governance/imb/5imbmeeting/imbreport_january2012.pdf.
26. Iliyasu Z, Nwaze E, Verma H, et al. Survey of poliovirus antibodies in Kano, Northern Nigeria 2013, National Primary Health Care Development Agency, Abuja, Nigeria.
27. Progress towards poliomyelitis eradication in Nigeria, January 2012-September 2013. Wkly Epidemiol Rec 2013, 88:533-548. WHO.